A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer
A disintegrin and metalloprotease 12 (ADAM12) has been implicated in cell growth, tumor formation, and metastasis. Therefore, we evaluated the role of ADAM12 in colorectal cancer (CRC) progression and prognosis, and elucidated whether targeted downregulation of ADAM12 could lead to therapeutic sensi...
Main Authors: | Young-Lan Park, Sun-Young Park, Hyung-Hoon Oh, Min-Woo Chung, Ji-Yun Hong, Ki-Hyun Kim, Dae-Seong Myung, Sung-Bum Cho, Wan-Sik Lee, Hyun-Soo Kim, Young-Eun Joo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1927 |
Similar Items
-
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
by: Nives Giebeler, et al.
Published: (2016-04-01) -
Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10
by: Dmitriy Minond, et al.
Published: (2020-05-01) -
Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: Implication in tumor progression and prognosis
by: Dalia M. Abd El-Rehim, et al.
Published: (2015-03-01) -
Identification of novel substrates of a disintegrin and metalloprotease 17 by specific labeling of surface proteins
by: Kazuki Omoteyama, et al.
Published: (2020-12-01) -
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
by: Bijlsma, M.F, et al.
Published: (2022)